JSW
SPPI

Journey Strategic Wealth’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Journey Strategic Wealth’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-42,301
Closed -$54K – 244
2021
Q4 		$54K Buy
+42,301
New +$75.6K 0.01% 208

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Journey Strategic Wealth's SPPI Position: Q1 2022 in Review

Journey Strategic Wealth sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 42,301 shares — an estimated $54K sold.

Journey Strategic Wealth first reported a position in SPPI in Q4 2021 and held it in 1 quarter. The position peaked at $54K in Q4 2021. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Journey Strategic Wealth reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Journey Strategic Wealth sold 42,301 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $54K.
  • Journey Strategic Wealth first reported a position in Spectrum Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Journey Strategic Wealth's Spectrum Pharmaceuticals Inc position peaked at $54K in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Journey Strategic Wealth's 13F filing for Q1 2022, filed 16 May 2022.